Nitric oxide and cancer therapy: the emperor has NO clothes

JR Hickok, DD Thomas - Current pharmaceutical design, 2010 - ingentaconnect.com
The role of nitric oxide (NO•) as a mediator of cancer phenotype has led researchers to
investigate strategies for manipulating in vivo production and exogenous delivery of this …

[HTML][HTML] Nitric oxide (NO) and NO synthases (NOS)-based targeted therapy for colon cancer

H Wang, L Wang, Z Xie, S Zhou, Y Li, Y Zhou, M Sun - Cancers, 2020 - mdpi.com
Colorectal cancer (CRC) is one of the most lethal malignancies worldwide and CRC therapy
remains unsatisfactory. In recent decades, nitric oxide (NO)—a free-radical gas—plus its …

Opportunities for nitric oxide in potentiating cancer immunotherapy

J Kim, SN Thomas - Pharmacological Reviews, 2022 - ASPET
Despite nearly 30 years of development and recent highlights of nitric oxide (NO) donors
and NO delivery systems in anticancer therapy, the limited understanding of exogenous …

Quinone methide bioactivation pathway: contribution to toxicity and/or cytoprotection?

J Louise Bolton - Current organic chemistry, 2014 - ingentaconnect.com
The formation of quinone methides (QMs) from either direct 2-electron oxidation of 2-or 4-
alkylphenols, isomerization of oquinones, or elimination of a good leaving group could …

Pharmacological manipulation of cGMP and NO/cGMP in CNS drug discovery

MA Hollas, MB Aissa, SH Lee, JM Gordon-Blake… - Nitric Oxide, 2019 - Elsevier
The development of small molecule modulators of NO/cGMP signaling for use in the CNS
has lagged far behind the use of such clinical agents in the periphery, despite the central …

New praziquantel derivatives containing NO-donor furoxans and related furazans as active agents against Schistosoma mansoni

S Guglielmo, D Cortese, F Vottero, B Rolando… - European journal of …, 2014 - Elsevier
A series of NO-donor praziquantel hybrid compounds was obtained by combining
praziquantel (PZQ) and furoxan moieties in a single entity. NO-donor properties of the …

Soluble guanylyl cyclase is a critical regulator of migraine-associated pain

M Ben Aissa, AF Tipton, Z Bertels, R Gandhi… - …, 2018 - journals.sagepub.com
Background Nitric oxide (NO) has been heavily implicated in migraine. Nitroglycerin is a
prototypic NO-donor, and triggers migraine in humans. However, nitroglycerin also induces …

The latest advances in the discovery of nitric oxide hybrid drug compounds

RAM Serafim, FG Pernichelle… - Expert Opinion on Drug …, 2017 - Taylor & Francis
Introduction: There is a great interest in Nitric oxide (NO) within medicinal chemistry since it's
involved in human signaling pathways. Prodrugs or hybrid compounds containing NO-donor …

Natural remedies for non‐steroidal anti‐inflammatory drug‐induced toxicity

JP Simon, S Evan Prince - Journal of Applied Toxicology, 2017 - Wiley Online Library
The liver is an important organ of the body, which has a vital role in metabolic functions. The
non‐steroidal anti‐inflammatory drug (NSAID), diclofenac causes hepato‐renal toxicity and …

Prospects of NSAIDs administration as double-edged agents against endometrial cancer and pathological species of the uterine microbiome

O Kuźmycz, P Stączek - Cancer biology & therapy, 2020 - Taylor & Francis
Many types of cancers, including endometrial cancer, were found to have cyclooxygenase-2
(COX-2) overexpression. Because this enzyme belongs to the group of pro-inflammatory …